Latest Breaking News On - Beacon pharmaceuticals - Page 22 : comparemela.com

Pharmas rake in higher profits Listed drug makers booked an 18 per cent growth in profit in the first nine months of the current fiscal year thanks to a decrease in marketing costs amidst the coronavirus pandemic. The figures and associated data were compiled by Prime Finance Asset Management Company, analysing 13 pharmaceuticals companies. ACI and Orion Pharmaceuticals were excluded as they are yet to disclose their earnings. The total profit of the listed medicine-makers rose to Tk 2,168 crore. Among them, the profits of eight rose. One of them was Beacon Pharmaceuticals, whose profit surged five times to Tk 75 crore. Operational excellence in productivity is the main reason for the higher growth in profits of drug makers, said Muhammad Zahangir Alam, chief financial officer of Square Pharmaceuticals. The company s profits rose around 11 per cent to Tk 1,163 crore.

Jubayer alamMir ariful islamMuhammad zahangir alamBeacon pharmaceuticalsAsset management companyReckitt benckiserDhaka stock exchangeBeximco pharmaceuticalsSquare pharmaceuticalsOrion pharmaceuticalsPrime finance asset management companyPrime finance asset managementIbn sina pharmaceuticalAcme laboratoriesமீர் அரிஃபுல் இஸ்லாம்பெக்கான் மருந்துகள்